Novo Nordisk has published phase 3b data on denecimig, an experimental treatment for haemophilia A.
Further verified details were not immediately available at the time of reporting.
Novo Nordisk publishes phase 3b data on denecimig for haemophilia A
Novo Nordisk has released phase 3b trial results for its experimental therapy denecimig targeting haemophilia A.
SL
Sophie Laurent · FX & Rates Desk · 17 Sept 2026 · 23:41 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
SL
Written by
Sophie Laurent
FX & Rates Desk
Sophie covers currency markets and central bank policy across Europe, with a focus on how rate decisions ripple through FX pairs. She has been tracking the ECB's policy path since the start of the current easing cycle.
More from Sophie Laurent →
